Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neuronex Inc.

Division of Acorda Therapeutics Inc.
www.neuronexinc.com

Latest From Neuronex Inc.

VC Roundup: Three New Funds Close As Small, Early Financings Bounce Back

Even Series A rounds have been large during recent record-breaking years for biotech venture capital investment, but it looks like smaller financings for early-stage companies may be in the midst of a comeback. With VC firms closing new funds, that raises the question: Will the number of preclinical and Phase I financings increase?

Companies Business Strategies

Acorda Drops Epilepsy Candidate Once Central To Its Revenue Forecasts

Plumiaz, a nasal spray formulation of diazepam, is discontinued after it fails one of three Phase III trials undertaken to comply with 2014 FDA complete response letter.

Companies Regulation

Acorda Drops Epilepsy Candidate Once Central To Its Revenue Forecasts

Plumiaz, a nasal spray formulation of diazepam, is discontinued after it fails one of three Phase III trials undertaken to comply with 2014 FDA complete response letter.

BioPharmaceutical United States

New Anti-Epileptic Drug Formulations Try To Overcome Tolerability Problems

Much of the drug development activity in epilepsy is focused on improving the existing treatments.

BioPharmaceutical Clinical Trials
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Acorda Therapeutics Inc.
  • Senior Management
  • Moise A Khayrallah, PhD, CEO
    Karen J Adams, Acting CFO
    Gary Bream, PhD, VP, Scientific Affairs
    Stephen E Butts, EVP, Commercial Ops.
  • Contact Info
  • Neuronex Inc.
    Phone: (919) 460-9500
    9001 Aerial Center Pkwy.
    Ste. 110
    Morrisville, NC 27560-9731
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register